600664:SHA
Harbin Pharmaceutical Group Co Ltd
CN¥6,19
arrow_upward
+0,49%(+0,030) 1D
15 Okt., 15:00:00 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600664...
Open
CN¥6,05
High
CN¥6,50
Low
CN¥5,99
Mkt. cap
16,52 mjd
Avg. vol.
382,73 m
Volume
377,39 m
P/E ratio
30,44
52-wk high
CN¥9,86
52-wk low
CN¥2,84
EPS
CN¥0,20
Shares outstanding
2,54 mjd
No. of employees
10 k
Open
CN¥6,05
High
CN¥6,50
Low
CN¥5,99
Mkt. cap
16,52 mjd
Avg. vol.
382,73 m
Volume
377,39 m
P/E ratio
30,44
52-wk high
CN¥9,86
52-wk low
CN¥2,84
EPS
CN¥0,20
Shares outstanding
2,54 mjd
No. of employees
10 k
News stories
From web sources and news partners
Benzinga
·
1 uur gelede
TruGolf Holdings (NASDAQ: TRUG) Taps Newly Acquired Polymath to Tokenize Franchise Ownership Records
The Olympian
·
40 minute gelede
Nasdaq reports network disruption, US equities data feeds impacted
CNN
·
6 uur gelede
Global tech sell-off deepens as enthusiasm for AI stocks wobbles
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd